On Apr. 2, 2020, an international team led by University of British Columbia (UBC) researcher Dr. Josef Penninger…
On Apr. 2, 2020, Vir Biotech and Alnylam Pharma announced an expansion to their broad multi-target existing collaboration…
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
On Apr. 1, 2020, Innovation Pharma announced BARDA had initiated funding to support the onshoring of Paratek manufacturing…
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….
On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 20, 2020, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine…
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…